CompletedPhase 1/2

Utilization of Amniotic Membrane Extract Eye Drop (AMEED) on Human Corneal Healing

20 participantsStarted 2014-06

Plain-language summary

For severe ocular surface diseases, such as chemical and thermal injuries, Stevens-Johnson syndrome (SJS), Band Keratopathy, Corneal Dystrophies, Refractive (PRK-LASEK), corneal surgery and others, it is important that short time treatment with minimal side effect should be considered. This study is a prospective clinical trial to use Amniotic Membrane Extract Eye Drop (AMEED) as a natural substance for acceleration of corneal healing

Who can participate

Age range20 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patient with corneal epithelium injury
✓. Without keratoconus
✓. Without cornea scar
✓. Without any other lesion of cornea

Exclusion criteria

✕. Lack of timely referral of patients for examinations
✕. Simultaneous use of other drugs that cause impairment of the data
✕. Previous cornea surgery
✕. Dry eye
✕. Glaucoma

What they're measuring

corneal defect size

Timeframe: 12 months

Trial details

NCT IDNCT02746848

SponsorRoyan Institute

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2015-05

View on ClinicalTrials.gov More Cornea Injury trials